SSRI medication use during pregnancy may increase the risk for GD and some poor newborn outcomes, but may protect against adverse outcomes.

Adam Urato, who is currently a vaccine advisor to the CDC, is closely associated with acting CDER director Tracy Beth Høeg and is a fellow skeptic of the use of selective serotonin reuptake inhibitors ...

Nearly two-thirds of women stop taking prescribed antidepressants during pregnancy, a 2026 cross-sectional analysis has found.

Monoamine oxidase inhibitors were linked to the highest risk for cardiovascular Standardized MedDRA Queries. Dopamine reuptake inhibition and binding inhibition are linked to antidepressant-related ...

A research team led by Professor Oh Yong-Seok of the Department of Brain Sciences at the Daegu Gyeongbuk Institute of Science ...

This is the first installment in a series of articles about the science of various aspects of college life. Use of selective serotonin reuptake inhibitors, or SSRIs, has increased among college ...

SSRIs enhance CD8 T cell antitumor activity by inhibiting SERT, an immune checkpoint in tumors, suggesting potential repurposing for cancer immunotherapy. High intratumoral SERT levels correlate with ...

Another phase III failure of Theravance Biopharma Inc.’s norepinephrine reuptake inhibitor ampreloxetine to treat symptomatic neurogenic orthostatic hypotension, this time in patients with the rare ...